- Home
- KPLT vs ATRA Comparison
KPLT vs ATRA Comparison
Compare KPLT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | ATRA |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | 94 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | KPLT | ATRA |
|---|---|---|
| Price | $6.70 | $9.63 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 2 |
| Target Price | ★ $10.00 | $5.00 |
| AVG Volume (30 Days) | 15.4K | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | $18.62 | N/A |
| Revenue Next Year | $15.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $3.92 |
| 52 Week High | $24.15 | $19.15 |
Technical Indicators
Market Signals| Indicator | KPLT | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 68.32 |
| Support Level | $6.63 | $4.35 |
| Resistance Level | $6.92 | $12.91 |
| Average True Range (ATR) | 0.31 | 1.16 |
| MACD | -0.05 | 0.55 |
| Stochastic Oscillator | 33.03 | 65.32 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).